Difficulty: Medium
Average Score: 71%
Testbank
The nurse is aware that the drug t-PA a tissue plasminogen activator, must be given within how many hours of the onset of symptoms to have maximum benefit?
Correct answer
A
Rationale
t-PA must be given within 3 hours of the onset of symptoms to achieve maximum therapeutic benefit.
Administering t-PA within 3 hours is critical as this timeframe significantly increases the chances of restoring blood flow and minimizing brain damage in patients experiencing an acute ischemic stroke. Studies have shown that outcomes improve dramatically when treatment is initiated promptly within this window.
B: 4 hours. While 4 hours may seem like a reasonable timeframe, it exceeds the optimal window for administering t-PA, which is crucial for maximizing recovery and minimizing neurological deficits.
C: 6 hours. Administering t-PA after 6 hours is beyond the recommended period and significantly reduces the effectiveness of the treatment, increasing the risk of complications and poor patient outcomes.
D: 8 hours. An 8-hour delay in administering t-PA is far too long and can lead to irreversible brain damage, making it ineffective for restoring blood flow and addressing the acute ischemic event.
Administering t-PA within 3 hours is critical as this timeframe significantly increases the chances of restoring blood flow and minimizing brain damage in patients experiencing an acute ischemic stroke. Studies have shown that outcomes improve dramatically when treatment is initiated promptly within this window.
B: 4 hours. While 4 hours may seem like a reasonable timeframe, it exceeds the optimal window for administering t-PA, which is crucial for maximizing recovery and minimizing neurological deficits.
C: 6 hours. Administering t-PA after 6 hours is beyond the recommended period and significantly reduces the effectiveness of the treatment, increasing the risk of complications and poor patient outcomes.
D: 8 hours. An 8-hour delay in administering t-PA is far too long and can lead to irreversible brain damage, making it ineffective for restoring blood flow and addressing the acute ischemic event.